Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.
about
Alkyne-azide "click" chemistry in designing nanocarriers for applications in biologyLiquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokineticsInvestigation of the neuroprotective impact of nimodipine on Neuro2a cells by means of a surgery-like stress modelHigh Compliance with Scheduled Nimodipine Is Associated with Better Outcome in Aneurysmal Subarachnoid Hemorrhage Patients Cotreated with Heparin InfusionLack of interaction between diazepam and nimodipine during chronic oral administration to healthy elderly subjects.Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients.Systematic review of reversible cerebral vasoconstriction syndrome.Cerebral oxygenation and haemodynamic effects induced by nimodipine in healthy subjects.Hot spots and future directions of research on the neuroprotective effects of nimodipine.Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage.What have drugs to offer the patient with acute stroke?A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid HemorrhageDrug interactions: Part I.Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study.Nimodipine rescues N-methyl-N-nitrosourea-induced retinal degeneration in ratsEffect of age on the pharmacokinetics of polymorphic nimodipine in rats after oral administrationNimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.Nimodipine-Loaded Pluronic® Block Copolymer Micelles: Preparation, Characterization, In-vitro and In-vivo Studies.1,4-dihydropyridines: the multiple personalities of a blockbuster drug family.Cytotoxic evaluation of injectable cyclodextrin nanoparticles.Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine.Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine.Development of an RP-HPLC-UV Method for Simultaneous Detection of Nimodipine and its Metabolite in Cerebrospinal Fluid of Rat.Nimodipine ameliorates trauma-induced cochlear neuronal death.Synergistic internal carotid vasodilator effects of human alpha-calcitonin gene-related peptide and nimodipine in conscious rats.Formulation and evaluation of nimodipine-loaded lipid microspheres.Physicochemical characterization of nimodipine-polyethylene glycol solid dispersion systems.Development and pharmacokinetics of nimodipine-loaded liposomes.Dose-response relationship of locally applied nimodipine in an ex vivo model of cerebral vasospasm.Influence of nimodipine on vasoconstrictor responses in the hindquarters vascular bed of the cat.A Sensitive Spectrophotometric Estimation of Nimodipine in Tablets and Injection Using Phloroglucinol
P2860
Q26995503-7CD24236-7AC6-4A14-94ED-33226B5DB7C6Q28706344-67774808-3FF4-40E3-95A3-4696E52DBB48Q30317009-4025B597-4B67-4717-B9EF-59A4E97CE7C8Q33780767-A3892A07-BDFA-438B-8C4E-8011D33480B4Q34346475-42BF7AA4-F433-461B-B353-8336E81C7DF9Q34358681-90A1A802-764F-4D30-8ED6-7DD975F17425Q34489830-88257692-F321-4E59-B648-C61D8F880315Q34583326-61F6FA9A-C4EB-4A63-A7CA-4FDCA25C45C4Q34798845-C452357A-DB38-4B8F-B551-8CAB539BA6B8Q35654964-36A5B0E8-75E9-4E32-9252-086B0C671871Q35834042-CBE90FDE-A024-4D90-9A00-4E4FC66A225FQ35943404-09461F2F-A8DD-4713-A772-D32D3888CEE9Q36138026-99F11F87-029A-4D05-8CBC-26E42FDDBDE9Q36148584-741B91AA-9F48-4896-9CBB-A863ACF8F27DQ36924251-3A1E5012-B8EA-4C23-B605-B6D416359210Q37302182-D36355EC-FBCE-4D30-997B-AEA3BCA84412Q37330158-D9C68686-7339-449F-A79B-A8067C35A216Q37651106-C4DD9A07-9E73-46A7-90D6-13F7A052564BQ38125687-A6EC22DE-FA40-43CF-843F-A8AC51CA96A7Q40287357-AC03A2B5-0ED0-4F46-910A-9092E0A792DFQ41109713-DB209B33-B25D-4DD8-BF7F-2105871B1B23Q41547567-DF131670-B1CF-4918-B893-3719C49D9B20Q41989672-88E850EB-4E6F-4537-ACE7-E1765E59925EQ42360542-577E6EDB-2474-4579-AB71-AFCCEE9DDA6CQ42435086-5FF4116A-D1C8-4AC4-A365-3DD106974FEAQ42563708-D17E3263-8C53-4511-8C1E-2D937C0492D7Q44223055-1D5D619F-95F0-4AF1-8C5B-490E1B4C8E72Q45983980-B95AA830-BB25-40A5-8DC6-38A902961F9AQ48432095-F60E2B5D-C019-45AB-AB09-7377D2A37F66Q53851472-0972F1FF-4145-4455-BDAB-713C057D78DAQ54130355-2D40DC7D-794C-4560-931D-C531C969461BQ59000805-2B32DF5D-87C1-48FB-9D41-40E85DF3ECD2
P2860
Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Nimodipine. A review of its ph ...... al in cerebrovascular disease.
@en
type
label
Nimodipine. A review of its ph ...... al in cerebrovascular disease.
@en
prefLabel
Nimodipine. A review of its ph ...... al in cerebrovascular disease.
@en
P1433
P1476
Nimodipine. A review of its ph ...... al in cerebrovascular disease.
@en
P2093
P304
P356
10.2165/00003495-198937050-00004
P577
1989-05-01T00:00:00Z
P6179
1023671808